| scholarly article | Q13442814 |
| P356 | DOI | 10.2337/DIAB.37.7.901 |
| P698 | PubMed publication ID | 3290007 |
| P2093 | author name string | R S Sherwin | |
| S A Amiel | |||
| W V Tamborlane | |||
| D C Simonson | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Insulin Therapy | Q2002370 |
| P304 | page(s) | 901-907 | |
| P577 | publication date | 1988-07-01 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release | |
| P478 | volume | 37 |
| Q44536807 | A characteristic reactive hypoglycemia induced by rapid change of eating behavior in anorexia nervosa: a case report |
| Q52649975 | Acidosis mediates recurrent hypoglycemia-induced increase in ischemic brain injury in treated diabetic rats. |
| Q35782351 | Adaptation in brain glucose uptake following recurrent hypoglycemia |
| Q54459003 | Adrenaline response to hypoglycaemia and insulin species. |
| Q40824384 | Adverse effects of exogenous insulin. Clinical features, management and prevention |
| Q57413100 | Alcohol causes hypoglycaemic unawareness in healthy volunteers and patients with Type 1 (insulin-dependent) diabetes |
| Q36975491 | Amplified hormonal counterregulatory responses to hypoglycemia in rats after systemic delivery of a SUR-1-selective K(+) channel opener? |
| Q51597579 | Biochemical evidence for the requirement of continuous glucose therapy in young adults with type 1 glycogen storage disease. |
| Q35561052 | Brain activation during working memory is altered in patients with type 1 diabetes during hypoglycemia |
| Q26777636 | Brain glucose metabolism during hypoglycemia in type 1 diabetes: insights from functional and metabolic neuroimaging studies |
| Q36842531 | Bringing light to the dark side of insulin: a journey across the blood-brain barrier |
| Q37361386 | Cardiac implications of hypoglycaemia in patients with diabetes - a systematic review |
| Q28080116 | Challenges in Modelling Hypoglycaemia-Associated Autonomic Failure: A Review of Human and Animal Studies |
| Q35279285 | Cortisol and growth hormone responses to spontaneous hypoglycaemia in infants and children |
| Q44637055 | Dead in Bed Syndrome: a New Manifestation of Nocturnal Hypoglycaemia? |
| Q48106101 | Defining relevant hypoglycemia measures in children and adolescents with type 1 diabetes |
| Q34812164 | Development of a multi-parametric model predictive control algorithm for insulin delivery in type 1 diabetes mellitus using clinical parameters |
| Q30416241 | Diabetes technology: markers, monitoring, assessment, and control of blood glucose fluctuations in diabetes |
| Q27027422 | Diabetes, insulin-mediated glucose metabolism and Sertoli/blood-testis barrier function |
| Q46688544 | Differential changes in brain glucose metabolism during hypoglycaemia accompany loss of hypoglycaemia awareness in men with type 1 diabetes mellitus. An [11C]-3-O-methyl-D-glucose PET study |
| Q35186418 | Double blind clinical and laboratory study of hypoglycaemia with human and porcine insulin in diabetic patients reporting hypoglycaemia unawareness after transferring to human insulin |
| Q36109086 | Early loss of the glucagon response to hypoglycemia in adolescents with type 1 diabetes |
| Q35823863 | Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. A comparison with insulin |
| Q36877083 | Effects of oral carbohydrate on autonomic nervous system counterregulatory responses during hyperinsulinemic hypoglycemia and euglycemia |
| Q34576063 | Exercise-related hypoglycemia in diabetes mellitus |
| Q52579817 | GPR119 Agonism Increases Glucagon Secretion During Insulin-Induced Hypoglycemia. |
| Q57420359 | Gender differences in counterregulation to hypoglycaemia |
| Q30276764 | Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes |
| Q57412784 | Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes |
| Q67805165 | Glucose counterregulation in type 1 diabetic patients with decreased symptoms of hypoglycemia after insulin pump treatment |
| Q27686872 | Glucose counterregulatory responses to hypoglycemia. |
| Q40390203 | Glycaemia control in diabetes mellitus. Towards the normal profile? |
| Q24645071 | Glycemic control and hypoglycemia: is the loser the winner? |
| Q38409082 | Haemodialysis-induced hypoglycaemia and glycaemic disarrays |
| Q38239582 | Human insulin |
| Q68312276 | Human insulin and awareness of acute hypoglycaemic symptoms in insulin-dependent diabetes |
| Q92824573 | Hypoglycaemia Awareness Restoration Programme for People with Type 1 Diabetes and Problematic Hypoglycaemia Persisting Despite Optimised Self-care (HARPdoc): protocol for a group randomised controlled trial of a novel intervention addressing cogniti |
| Q67906265 | Hypoglycaemia Unawareness in Type 1 Diabetes: A Lower Plasma Glucose is Required to Stimulate Sympathoadrenal Activation |
| Q55476876 | Hypoglycaemia in diabetes: do we think enough of the cause? An observational study on prevalence and causes of hypoglycaemia among patients with type 2 diabetes in an out-patient setting in Sri Lanka. |
| Q30299941 | Hypoglycemia Reduction and Accuracy of Continuous Glucose Monitoring |
| Q36782795 | Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society |
| Q69576561 | Hypoglycemia in diabetes among children and adolescents |
| Q36240009 | Hypoglycemia in the Treated Diabetic Patient: A Risk of intensive Insulin Therapy |
| Q34072593 | Hypoglycemia in type 1 diabetes mellitus |
| Q42542558 | Hypoglycemia--a major risk of insulin therapy. |
| Q36926342 | Hypoglycemia-Associated Autonomic Failure in Diabetes: Maladaptive, Adaptive, or Both? |
| Q33892550 | Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia |
| Q52624653 | Hypoglycemia: Role of Hypothalamic Glucose-Inhibited (GI) Neurons in Detection and Correction. |
| Q42555363 | Hypoglycemia: from the laboratory to the clinic |
| Q30432525 | Impact of blood glucose self-monitoring errors on glucose variability, risk for hypoglycemia, and average glucose control in type 1 diabetes: an in silico study |
| Q33909644 | Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. Reversibility and stimulus specificity of the deficits |
| Q50126689 | Impaired hypoglycaemia awareness in type 1 diabetes: lessons from the lab. |
| Q34370777 | Increased brain monocarboxylic acid transport and utilization in type 1 diabetes |
| Q35973277 | Inhaled Formoterol Diminishes Insulin-Induced Hypoglycemia in Type 1 Diabetes |
| Q26748833 | Insights into the role of neuronal glucokinase |
| Q35168333 | Insulin |
| Q28074690 | Insulin glargine 300 U/mL in the management of diabetes: clinical utility and patient perspectives |
| Q37223046 | Insulin signaling in alpha cells modulates glucagon secretion in vivo |
| Q35181629 | Intensified conventional insulin treatment and neuropsychological impairment |
| Q40831331 | Intensified insulin therapy. |
| Q30442016 | Is glycemic variability important to assessing antidiabetes therapies? |
| Q36868102 | Lack of association between residual insulin production and glucagon response to hypoglycemia in youth with short duration of type 1 diabetes |
| Q57420328 | Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM |
| Q71469942 | Long-term intensive insulin therapy in IDDM: effects on HbA1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia |
| Q72643714 | Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM |
| Q34349037 | Neuroendocrine responses to hypoglycemia |
| Q30276532 | Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report |
| Q36924597 | Past, present, and future of insulin pump therapy: better shot at diabetes control |
| Q35153950 | Pathophysiology of diabetes. A review of selected recent developments and their impact on treatment |
| Q39451576 | Perioperative management of endocrine insufficiency after total pancreatectomy for neoplasia |
| Q38365463 | Pharmacology of new hormonal therapies in the treatment of pediatric endocrine disorders. |
| Q36926325 | Philip E. Cryer, MD: Seminal Contributions to the Understanding of Hypoglycemia and Glucose Counterregulation and the Discovery of HAAF (Cryer Syndrome) |
| Q46239049 | Preventing hypoglycaemia: what is the appropriate glucose alert value? |
| Q37370189 | Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responses |
| Q57413089 | Prolonged but partial impairment of the hypoglycaemic physiological response following short-term hypoglycaemia in normal subjects |
| Q35282392 | Pubertal stage and hypoglycaemia counterregulation in type 1 diabetes |
| Q36685459 | Recent developments in insulin delivery techniques. Current status and future potential |
| Q37193674 | Recurrent antecedent hypoglycemia alters neuronal oxidative metabolism in vivo |
| Q36536812 | Regional brain activation during hypoglycemia in type 1 diabetes. |
| Q43812667 | Reproducibility of glycaemic thresholds for activation of counterregulatory hormones and hypoglycaemic symptoms in healthy subjects |
| Q38159475 | Severe hypoglycaemia in type 1 diabetes mellitus: underlying drivers and potential strategies for successful prevention. |
| Q37066918 | Small decrements in systemic glucose provoke increases in hypothalamic blood flow prior to the release of counterregulatory hormones |
| Q93085223 | Sodium nitroprusside prevents the detrimental effects of glucose on the neurovascular unit and behaviour in zebrafish |
| Q42481157 | Surgical removal of insulinoma restores glucose recovery from hypoglycaemia but does not normalize insulin action |
| Q35704111 | The pursuit of perfect control in diabetes |
| Q36679568 | The renaissance of insulin pump treatment in childhood type 1 diabetes |
| Q36772461 | Total pancreatectomy: indications, operative technique, and postoperative sequelae |
| Q35583882 | Treatment and prevention of hypoglycemia and its unawareness in type 1 diabetes mellitus |
| Q42762802 | Unawareness of hypoglycaemia and human insulin |
| Q44307774 | Unexplained Deaths of Type 1 Diabetic Patients |
| Q35881959 | Update on strategies limiting iatrogenic hypoglycemia |
| Q92070444 | Ventromedial hypothalamus glucose-inhibited neurones: A role in glucose and energy homeostasis? |
| Q53675800 | [Total pancreatectomy for mucinous pancreatic tumor] |
Search more.